Anesthesiology and Intensive Care; Anesthesia and Critical Care Department B, Saint Eloi Teaching Hospital, PhyMedExp, University of Montpellier, INSERM U1046, 1, 80 Avenue Augustin Fliche, Montpellier Cedex 5, 34295, Montpellier, France.
Centre Hospitalier Universitaire Montpellier, 34295, Montpellier, France.
Intensive Care Med. 2024 Aug;50(8):1265-1274. doi: 10.1007/s00134-024-07522-4. Epub 2024 Jul 29.
Although noninvasive ventilation (NIV) may reduce reintubation in patients with acute hypoxemic respiratory failure following abdominal surgery, this strategy has not been specifically assessed in patients with obesity.
We conducted a post hoc analysis of a multicenter randomized controlled trial comparing NIV delivered via facial mask to standard oxygen therapy among patients with obesity and acute hypoxemic respiratory failure within 7 days after abdominal surgery. The primary outcome was reintubation within 7 days. Secondary outcomes were invasive ventilation-free days at day 30, intensive care unit (ICU)-acquired pneumonia and 30-day survival.
Among 293 patients with hypoxemic respiratory failure following abdominal surgery, 76 (26%) patients had obesity and were included in the intention-to-treat analysis. Reintubation rate was significantly lower with NIV (13/42, 31%) than with standard oxygen therapy (19/34, 56%) within 7 days (absolute difference: - 25%, 95% confidence interval (CI) - 49 to - 1%, p = 0.03). NIV was associated with significantly more invasive ventilation-free days compared with standard oxygen therapy (27.1 ± 8.6 vs 22.7 ± 11.1 days; p = 0.02), while fewer patients developed ICU-acquired pneumonia (1/42, 2% vs 6/34, 18%; p = 0.04). The 30-day survival was 98% in the NIV group (41/42) versus 85% in the standard oxygen therapy (p = 0.08). In patients with body mass index (BMI) < 30 kg/m, no significant difference was observed between NIV (36/105, 34%) and standard oxygen therapy (47/109, 43%, p = 0.03). An interaction test showed no statistically significant difference between the two subsets (BMI ≥ 30 kg/m and BMI < 30 kg/m).
Among patients with obesity and hypoxemic respiratory failure following abdominal surgery, use of NIV compared with standard oxygen therapy reduced the risk of reintubation within 7 days, contrary to patients without obesity. However, no interaction was found according to the presence of obesity or not, suggesting either a lack of power to conclude in the non-obese subgroup despite existing differences, or that the statistical difference found in the overall sample was driven by a large effect in the obese subsets.
尽管无创通气(NIV)可能减少腹部手术后急性低氧性呼吸衰竭患者的再插管,但在肥胖患者中尚未对此策略进行专门评估。
我们对一项多中心随机对照试验进行了事后分析,该试验比较了面罩通气的 NIV 与标准氧疗在腹部手术后 7 天内发生急性低氧性呼吸衰竭的肥胖患者中的疗效。主要结局为 7 天内再插管。次要结局为第 30 天无有创通气天数、重症监护病房(ICU)获得性肺炎和 30 天生存率。
在 293 例腹部手术后发生低氧性呼吸衰竭的患者中,76 例(26%)肥胖患者被纳入意向治疗分析。与标准氧疗相比,NIV 组在 7 天内的再插管率显著更低(13/42,31% vs 19/34,56%)(绝对差异:-25%,95%置信区间(CI)-49 至-1%,p=0.03)。与标准氧疗相比,NIV 组的无有创通气天数显著更长(27.1±8.6 天 vs 22.7±11.1 天;p=0.02),且更少的患者发生 ICU 获得性肺炎(1/42,2% vs 6/34,18%;p=0.04)。NIV 组的 30 天生存率为 98%(41/42),标准氧疗组为 85%(85/99)(p=0.08)。在 BMI<30kg/m 的患者中,NIV(36/105,34%)与标准氧疗(47/109,43%)之间无显著差异(p=0.03)。交互检验显示两组之间无统计学差异(BMI≥30kg/m 和 BMI<30kg/m)。
在腹部手术后发生低氧性呼吸衰竭的肥胖患者中,与标准氧疗相比,NIV 降低了 7 天内再插管的风险,这与非肥胖患者相反。然而,根据是否存在肥胖,并未发现交互作用,这提示尽管存在差异,但在非肥胖亚组中缺乏得出结论的能力,或者在总体样本中发现的统计学差异是由肥胖亚组中的大效应驱动的。